Global Insulin Like Growth Factor II Market Status and Outlook 2018-2025

August 2018 | 113 pages | ID: GE382441FBBEN
99Strategy

Abstracts

Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies

• Boehringer Ingelheim GmbH
• Genervon Biopharmaceuticals LLC
• MedImmune LLC

Market by Type

• Dusigitumab
• M-630
• GM-6
• M-610.27
• Xentuzumab
• Others

Market by Application

• Breast Cancer
• Hormone Sensitive Breast Cancer
• Huntington Disease
• Muscular Dystrophy
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Insulin Like Growth Factor II Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Dusigitumab
  3.1.2 M-630
  3.1.3 GM-6
  3.1.4 M-610.27
  3.1.5 Xentuzumab
  3.1.6 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Breast Cancer
  4.1.2 Hormone Sensitive Breast Cancer
  4.1.3 Huntington Disease
  4.1.4 Muscular Dystrophy
  4.1.5 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Dusigitumab Production by Region
    6.1.1.2 M-630 Production by Region
    6.1.1.3 GM-6 Production by Region
    6.1.1.4 M-610.27 Production by Region
    6.1.1.5 Xentuzumab Production by Region
    6.1.1.6 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Breast Cancer Production by Region
    6.1.2.2 Hormone Sensitive Breast Cancer Production by Region
    6.1.2.3 Huntington Disease Production by Region
    6.1.2.4 Muscular Dystrophy Production by Region
    6.1.2.5 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Dusigitumab Demand by Region
    6.2.1.2 M-630 Demand by Region
    6.2.1.3 GM-6 Demand by Region
    6.2.1.4 M-610.27 Demand by Region
    6.2.1.5 Xentuzumab Demand by Region
    6.2.1.6 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Breast Cancer Demand by Region
    6.2.2.2 Hormone Sensitive Breast Cancer Demand by Region
    6.2.2.3 Huntington Disease Demand by Region
    6.2.2.4 Muscular Dystrophy Demand by Region
    6.2.2.5 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Boehringer Ingelheim GmbH
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Genervon Biopharmaceuticals LLC
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 MedImmune LLC
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Insulin Like Growth Factor II Industry Dynamics & Regulations List
Table Global Insulin Like Growth Factor II Sales Revenue, Cost and Margin, 2015-2018E
Table Global Insulin Like Growth Factor II Market Status by Type 2015-2018E, in USD Million
Table Global Insulin Like Growth Factor II Market Status by Application 2015-2018E, in USD Million
Table Global Insulin Like Growth Factor II Market Status by Application 2015-2018E, in Volume
Table Global Insulin Like Growth Factor II Market by Region 2015-2018E, in USD Million
Table Global Insulin Like Growth Factor II Market Share by Region in 2018, in USD Million
Table Global Insulin Like Growth Factor II Market by Region 2015-2018E, in Volume
Table Global Insulin Like Growth Factor II Market Share by Region in 2018, in Volume
Table Dusigitumab Production Value by Region 2015-2018E, in USD Million
Table Dusigitumab Production Volume by Region 2015-2018E, in Volume
Table M-630 Production Value by Region 2015-2018E, in USD Million
Table M-630 Production Volume by Region 2015-2018E, in Volume
Table GM-6 Production Value by Region 2015-2018E, in USD Million
Table GM-6 Production Volume by Region 2015-2018E, in Volume
Table M-610.27 Production Value by Region 2015-2018E, in USD Million
Table M-610.27 Production Volume by Region 2015-2018E, in Volume
Table Xentuzumab Production Value by Region 2015-2018E, in USD Million
Table Xentuzumab Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Breast Cancer Production Value by Region 2015-2018E, in USD Million
Table Breast Cancer Production Volume by Region 2015-2018E, in Volume
Table Hormone Sensitive Breast Cancer Production Value by Region 2015-2018E, in USD Million
Table Hormone Sensitive Breast Cancer Production Volume by Region 2015-2018E, in Volume
Table Huntington Disease Production Value by Region 2015-2018E, in USD Million
Table Huntington Disease Production Volume by Region 2015-2018E, in Volume
Table Muscular Dystrophy Production Value by Region 2015-2018E, in USD Million
Table Muscular Dystrophy Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Dusigitumab Market Size by Region 2015-2018E, in USD Million
Table Dusigitumab Market Size by Region 2015-2018E, in Volume
Table M-630 Market Size by Region 2015-2018E, in USD Million
Table M-630 Market Size by Region 2015-2018E, in Volume
Table GM-6 Market Size by Region 2015-2018E, in USD Million
Table GM-6 Market Size by Region 2015-2018E, in Volume
Table M-610.27 Market Size by Region 2015-2018E, in USD Million
Table M-610.27 Market Size by Region 2015-2018E, in Volume
Table Xentuzumab Market Size by Region 2015-2018E, in USD Million
Table Xentuzumab Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Breast Cancer Market Size by Region 2015-2018E, in USD Million
Table Breast Cancer Market Size by Region 2015-2018E, in Volume
Table Hormone Sensitive Breast Cancer Market Size by Region 2015-2018E, in USD Million
Table Hormone Sensitive Breast Cancer Market Size by Region 2015-2018E, in Volume
Table Huntington Disease Market Size by Region 2015-2018E, in USD Million
Table Huntington Disease Market Size by Region 2015-2018E, in Volume
Table Muscular Dystrophy Market Size by Region 2015-2018E, in USD Million
Table Muscular Dystrophy Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalInsulin Like Growth Factor II Forecast by Type 2019F-2025F, in USD Million
Table Insulin Like Growth Factor II Forecast by Type 2019F-2025F, in Volume
Table Insulin Like Growth Factor II Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Insulin Like Growth Factor II Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Insulin Like Growth Factor II Market Forecast by Region 2019F-2025F, in USD Million
Table Insulin Like Growth Factor II Market Forecast by Region 2019F-2025F, in Volume
Table Boehringer Ingelheim GmbH Information
Table Insulin Like Growth Factor II Sales, Cost, Margin of Boehringer Ingelheim GmbH
Table Genervon Biopharmaceuticals LLC Information
Table Insulin Like Growth Factor II Sales, Cost, Margin of Genervon Biopharmaceuticals LLC
Table MedImmune LLC Information
Table Insulin Like Growth Factor II Sales, Cost, Margin of MedImmune LLC
Table Global Insulin Like Growth Factor II Sales Revenue by Company 2015-2017, in USD Million
Table Global Insulin Like Growth Factor II Sales Volume by Company 2015-2017, in Volume
Table Global Insulin Like Growth Factor II Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Insulin Like Growth Factor II Picture
Figure Insulin Like Growth Factor II Industry Chain Diagram
Figure Global Insulin Like Growth Factor II Sales Revenue 2015-2018E, in USD Million
Figure Global Insulin Like Growth Factor II Sales Volume 2015-2018E, in Volume
Figure Global Insulin Like Growth Factor II Market Status by Type 2015-2018E, in Volume
Figure North America Insulin Like Growth Factor II Market Size and Growth 2015-2018E, in USD Million
Figure North America Insulin Like Growth Factor II Market Size and Growth 2015-2018E, in Volume
Figure Europe Insulin Like Growth Factor II Market Size and Growth 2015-2018E, in USD Million
Figure Europe Insulin Like Growth Factor II Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Insulin Like Growth Factor II Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Insulin Like Growth Factor II Market Size and Growth 2015-2018E, in Volume
Figure South America Insulin Like Growth Factor II Market Size and Growth 2015-2018E, in USD Million
Figure South America Insulin Like Growth Factor II Market Size and Growth 2015-2018E, in Volume
Figure Middle East Insulin Like Growth Factor II Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Insulin Like Growth Factor II Market Size and Growth 2015-2018E, in Volume
Figure Africa Insulin Like Growth Factor II Market Size and Growth 2015-2018E, in USD Million
Figure Africa Insulin Like Growth Factor II Market Size and Growth 2015-2018E, in Volume
Figure Global Insulin Like Growth Factor II Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Insulin Like Growth Factor II Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Insulin Like Growth Factor II Sales Price Forecast 2019F-2025F
Figure Global Insulin Like Growth Factor II Gross Margin Forecast 2019F-2025F
Figure Global Insulin Like Growth Factor II Sales Revenue by Company in 2018, in USD Million
Figure Global Insulin Like Growth Factor II Price by Company in 2018
Figure Global Insulin Like Growth Factor II Gross Margin by Company in 2018